Patent Baristas

Wisconsin Governor Jim Doyle held a press conference this afternoon on why Wisconsin is way more than cheese.  Announcing that the Genetics Policy Institute picked Wisconsin as the host of the World Stem Cell Summit 2008, Gov. Doyle laid out how the state is on pace in building the Wisconsin Institutes for Discovery at the […]

I’m excited to be attending BIO2008 Conference in San Diego this week where I’ll be participating as an on-site blogger via the BioOnTheRoad (at bioontheroad.org/) blog — similar to last year’s BIO Voice — the blog of the BIO2008 conference. It’ll be fun to see an up-to-the-minute review of some of the sights and sounds […]

Lewis & Clark Law Review’s latest issue and it features a business forum on the Supreme Court’s recent patent decision in KSR v. Teleflex. If you want to talk KSR, this is your stop.  There are eleven action-packed articles related to this decision and this is a great way to get your fill of opinions. […]

“Biotechnology is not merely a set of technologies, but also an underlying philosophy of entrepreneurship, risk-taking and long-term vision.”  ~BioSynergy Students at the Massachusetts Institute of Technology (MIT), Stanford University and the University of Toronto have launched a new biotech magazine called BioSynergy.  Their stated goal is to “[C]atalyze the birth of the next generation […]

Generic drug maker Mylan got some good news from the U.S. Court of Appeals for the Federal Circuit in a patent litigation related to its heartburn treatment Omeprazole, the generic version of British drug maker AstraZeneca’s Prilosec, when the court affirmed a District Court ruling that Mylan’s 10 mg and 20 mg Omeprazole delayed-release capsules […]

The U.S. Patent and Trademark Office (USPTO) published some new rules that will improve (their word, not ours) the process of ex parte appeals before the USPTO’s Board of Patent Appeals and Interferences (BPAI). The rules are supposed to help to streamline the appeal process and lead to more timely Board decisions.  We’ll see. The […]

BioOhio Reception: an evening at the OhiOasis June 18, 5:30-8pm @ Buster’s Beach House, Seaport Village BioOhio will be passing around cocktails, island-influenced hors d’oeuvres and some great networking opportunities at BIO 2008 with biotech and biomed industry and research leaders as well as others involved in bioscience innovation and commercialization. The evening will feature […]

The U.S. Court of Appeals for the Federal Circuit looked at the issue of whether Aventis committed that most horrible of patent sins — inequitable conduct before the United States Patent and Trademark Office (PTO).   Aventis Pharma v. Amphastar and Teva (07-1280) . Earlier, the CAFC held that the dosage of the prior art composition […]